The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Serum neuron-specific enolase in the major subtypes of status epilepticus
Abstract
OBJECTIVES: To determine the relative magnitudes of neuron-specific enolase (NSE) levels after complex partial status epilepticus (SE), absence SE, generalized convulsive SE, and subclinical generalized convulsive SE (frequently referred to as acute symptomatic myoclonic status epilepticus). BACKGROUND: NSE is a marker of acute brain injury and blood-brain barrier dysfunction, which is elevated in SE. METHODS: Serum NSE levels were drawn in 31 patients 1, 2, 3, and 7 days after SE. Patients were classified as acute symptomatic or remote symptomatic, and the duration and outcome of SE were determined and correlated with the peak NSE level. RESULTS: NSE was elevated significantly in all four subtypes of SE, but NSE levels were highest in complex partial and subclinical SE. The mean peak NSE level for the complex partial SE group was 23.88 ng/mL (n = 12), 21.5 ng/mL for absence SE (n = 1), 14.10 ng/mL for the generalized convulsive SE group (n = 12), and 37.83 ng/mL for the subclinical SE group (n = 6), all of which was significantly higher than normal control subjects (5.02 ng/mL). Outcome was significantly different between the three groups (p = 0.0007), and was significantly worse for subclinical SE (p = 0.0005, subclinical versus generalized convulsive SE). CONCLUSION: Serum NSE levels were highest in complex partial and subclinical generalized convulsive SE. The extremely high levels of NSE in subclinical SE reflect the severity of the acute neurologic insults and poor outcome common to subclinical SE. High NSE levels in complex partial SE reflects the long duration of SE in this subgroup, and potential for brain injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Chong, D. J., & Hirsch, L. J. (2005) · Journal of Clinical Neurophysiology · doi:10.1097/01.wnp.0000158699.78529.af · Cited by 500
Geschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L. (2008) · Annals of Neurology · doi:10.1002/ana.21430 · Cited by 323
Continuous Electroencephalogram Monitoring in the Intensive Care Unit
Friedman, D., Claassen, J., & Hirsch, L. J. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181a9d8b5 · Cited by 309
Non-convulsive status epilepticus in adults: clinical forms and treatment
Meierkord, H., & Holtkamp, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70074-1 · Cited by 265
Metadata
- Authors
- DeGiorgio, C. M., Heck, C. N., Rabinowicz, A. L., Gott, P. S., Smith, T., & Correale, J.
- Venue
- Neurology
- Published
- 1999-03
- Volume
- 52
- Issue
- 4
- Pages
- 746-746
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2003364181
- Cited by
- 165
- References
- 1
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum neuron-specific enolase in the major subtypes of status epilepticus. https://app.cochat.ai/papers/10.1212/wnl.52.4.746
- The paper
- DeGiorgio, C. M., Heck, C. N., Rabinowicz, A. L., Gott, P. S., Smith, T., & Correale, J. (1999). Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology. https://doi.org/10.1212/wnl.52.4.746
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.